Suzuki Ayako, Angulo Paul, St Sauver Jennifer, Muto Ayako, Okada Toshihide, Lindor Keith
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA.
Am J Gastroenterol. 2007 Sep;102(9):1912-9. doi: 10.1111/j.1572-0241.2007.01274.x. Epub 2007 May 17.
The effect of light to moderate alcohol consumption on the liver is controversial. To determine the association between light to moderate alcohol consumption and frequency of hypertransaminasemia, a cross-sectional and a subsequent longitudinal cohort study were conducted using annual health checkup data at a Japanese workplace.
We analyzed 1,177 male subjects (age 20-59) without HCV or HBV infection or other chronic liver diseases. To determine the association between alcohol consumption (none or minimal <70 g/wk, light > or =70 g and <140 g/wk, moderate > or =140 g and <280 g/wk, excessive > or =280 g/wk) and hypertransaminasemia, we performed multiple logistic regressions. We then followed 326 subjects without a history of fatty liver or hypertransaminasemia up to 5 years for incidental hypertransaminasemia and performed Cox proportional hazard regressions.
Excess alcohol consumption was associated with increased odds of hypertransaminasemia (adjusted odds ratio [AOR]versus none or minimal consumption 1.4[1.1-1.93], P= 0.023). There was significant interaction between age group and alcohol consumption (P < 0.01). In the younger group, moderate consumption was associated with decreased odds (AOR 0.5 [0.3-0.9], P= 0.032), while in the older group, light consumption was associated with decreased odds (AOR 0.6 [0.4-1.0], P= 0.036) and excess consumption was associated with increased odds (AOR 1.6 [1.1-2.3], P= 0.014) of hypertransaminasemia. During follow-up, moderate consumption was associated with decreased incidence of hypertransaminasemia versus none or minimal consumption (adjusted hazard ratio 0.4 [0.1-0.9], P= 0.02).
Light to moderate alcohol consumption may protect against the development of hypertransaminasemia among male subjects without other liver conditions. Further studies are required before recommending light to moderate alcohol consumption.
轻度至中度饮酒对肝脏的影响存在争议。为了确定轻度至中度饮酒与高转氨酶血症发生频率之间的关联,我们利用日本一家工作场所的年度健康检查数据进行了一项横断面研究以及后续的纵向队列研究。
我们分析了1177名未感染丙型肝炎病毒(HCV)或乙型肝炎病毒(HBV)以及无其他慢性肝病的男性受试者(年龄20 - 59岁)。为了确定饮酒量(不饮酒或极少饮酒<70克/周、轻度饮酒≥70克且<140克/周、中度饮酒≥140克且<280克/周、过量饮酒≥280克/周)与高转氨酶血症之间的关联,我们进行了多项逻辑回归分析。然后,我们对326名无脂肪肝或高转氨酶血症病史的受试者进行了长达5年的随访,观察偶发性高转氨酶血症的发生情况,并进行了Cox比例风险回归分析。
过量饮酒与高转氨酶血症几率增加相关(调整后的优势比[AOR]与不饮酒或极少饮酒相比为1.4[1.1 - 1.93],P = 0.023)。年龄组与饮酒量之间存在显著交互作用(P < 0.01)。在较年轻组中,中度饮酒与几率降低相关(AOR 0.5[0.3 - 0.9],P = 0.032),而在较年长组中,轻度饮酒与几率降低相关(AOR 0.6[0.4 - 1.0],P = 0.036),过量饮酒与高转氨酶血症几率增加相关(AOR 1.6[1.1 - 2.3],P = 0.014)。在随访期间,与不饮酒或极少饮酒相比,中度饮酒与高转氨酶血症发病率降低相关(调整后的风险比0.4[0.1 - 0.9],P = 0.02)。
对于无其他肝脏疾病的男性受试者,轻度至中度饮酒可能预防高转氨酶血症的发生。在推荐轻度至中度饮酒之前,还需要进一步研究。